Paolo Rigano

1.2k total citations
33 papers, 524 citations indexed

About

Paolo Rigano is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Paolo Rigano has authored 33 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Genetics, 18 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Paolo Rigano's work include Hemoglobinopathies and Related Disorders (32 papers), Iron Metabolism and Disorders (16 papers) and Blood groups and transfusion (6 papers). Paolo Rigano is often cited by papers focused on Hemoglobinopathies and Related Disorders (32 papers), Iron Metabolism and Disorders (16 papers) and Blood groups and transfusion (6 papers). Paolo Rigano collaborates with scholars based in Italy, United States and United Kingdom. Paolo Rigano's co-authors include Aurelio Maggio, Disma Renda, Roberta Calzolari, Rosalba Di Marzo, Maria Concetta Renda, Gian Luca Forni, Marcello Capra, Aldo Filosa, Luigi Mancuso and Maria Domenica Cappellini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Paolo Rigano

33 papers receiving 488 citations

Peers

Countries citing papers authored by Paolo Rigano

Since Specialization

Citations

This map shows the geographic impact of Paolo Rigano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Rigano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Rigano more than expected).

Fields of papers citing papers by Paolo Rigano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Rigano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Rigano. The network helps show where Paolo Rigano may publish in the future.

Co-authorship network of co-authors of Paolo Rigano

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Rigano. A scholar is included among the top collaborators of Paolo Rigano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Rigano. Paolo Rigano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm 2021 ·HemaSphere ·D Baronciani, Maddalena Casale, Lucia De Franceschi, Giovanna Graziadei, Filomena Longo, Raffaella Origa, Paolo Rigano, Valeria Maria Pinto, Monia Marchetti, (unknown), Achille Iolascon, Gian Luca Forni, (unknown)	6
2	Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm 2019 ·Blood ·D Baronciani, Maddalena Casale, Lucia De Franceschi, Giovanna Graziadei, Filomena Longo, Raffaella Origa, Valeria Maria Pinto, Paolo Rigano, Monia Marchetti, (unknown), Emanuele Angelucci, Maria Domenica Cappellini, Achille Iolascon, Antonio Piga, Gian Luca Forni	2
3	Treatment of hepatitis C virus infection with direct‐acting antiviral drugs is safe and effective in patients with hemoglobinopathies 2017 ·American Journal of Hematology ·Raffaella Origa, (unknown), Aldo Filosa, Alfonso Galeota Lanza, Antonio Piga, Giorgio Maria Saracco, Valeria Maria Pinto, A. Picciotto, Paolo Rigano, Salvatore Madonia, Rosamaria Rosso, Domenico Giuseppe D’Ascola, Maria Domenica Cappellini, Roberta D’Ambrosio, Immacolata Tartaglione, Lucia De Franceschi, Barbara Gianesin, V. Di Marco, Gian Luca Forni, (unknown)	32
4	Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent 2017 ·Blood Cells Molecules and Diseases ·Paolo Rigano, Lucia De Franceschi, Laura Sainati, Antonio Piga, Frédéric B. Piel, Maria Domenica Cappellini, Carmelo Fidone, Nicoletta Masera, Giovanni Palazzi, Barbara Gianesin, Gian Luca Forni	34
5	Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey 2017 ·Pediatric Blood & Cancer ·Raffaella Colombatti, Giovanni Palazzi, Nicoletta Masera, Lucia Dora Notarangelo, Elisa Bonetti, Piera Samperi, Angelica Barone, Silverio Perrotta, Elena Facchini, Maurizio Miano, Giancarlo Vecchio, (unknown), Paola Corti, (unknown), Simone Cesaro, Maddalena Casale, Paolo Rigano, Gian Luca Forni, Giovanna Russo, Laura Sainati	24
6	Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β -Thalassemia Patients 2015 ·Hemoglobin ·(unknown), (unknown), Roberta Calzolari, Concetta Scazzone, Paolo Rigano, Adriana Martorana, (unknown), Aurelio Maggio, Rosalba Di Marzo	27
7	Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial 2014 ·Blood Cells Molecules and Diseases ·(unknown), Angela Vitrano, Rosario Di Maggio, Samir K. Ballas, Martin H. Steinberg, Paolo Rigano, (unknown), Paul Telfer, Disma Renda, Rita Barone, Aurelio Maggio	16
8	Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major 2013 ·Blood Cells Molecules and Diseases ·Aldo Filosa, Angela Vitrano, Paolo Rigano, Giuseppina Calvaruso, Rita Barone, Marcello Capra, Liana Cuccia, Francesco Gagliardotto, Lorella Pitrolo, Luciano Prossomariti, Maddalena Casale, Vincenzo Caruso, Calogera Gerardi, Saveria Campisi, Paolo Cianciulli, Michele Rizzo, Giuseppe D'Ascola, Angela Ciancio, Aurelio Maggio	26
9	Cerebrovascular events in sickle cell‐beta thalassemia treated with hydroxyurea: A single center prospective survey in adult Italians 2013 ·American Journal of Hematology ·Paolo Rigano, (unknown), Giuseppina Calvaruso, Martin H. Steinberg, (unknown), Aurelio Maggio	19
10	Neridronate improves bone mineral density and reduces back pain in β‐thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel‐arm, open‐label study 2012 ·British Journal of Haematology ·Gian Luca Forni, Silverio Perrotta, Andrea Giusti, Giovanni Quarta, Lorella Pitrolo, Maria Domenica Cappellini, Domenico Giuseppe D’Ascola, Caterina Borgna Pignatti, Paolo Rigano, Aldo Filosa, Giovanni Iolascon, Brúno Nobili, Marina Baldini, (unknown), Valeria Maria Pinto, Ernesto Palummeri	35
11	Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients 2012 ·American Journal of Hematology ·Aurelio Maggio, Angela Vitrano, (unknown), Marcello Capra, Liana Cuccia, Francesco Gagliardotto, Lorella Pitrolo, Luciano Prossomariti, Aldo Filosa, Vincenzo Caruso, Calogera Gerardi, Saveria Campisi, Paolo Cianciulli, Michele Rizzo, Giuseppe D'Ascola, Angela Ciancio, Rosario Di Maggio, Giuseppina Calvaruso, (unknown), Paolo Rigano	30
12	Reliability of EMA Binding Test in the Diagnosis of Hereditary Spherocytosis in Italian Patients 2010 ·Acta Haematologica ·(unknown), (unknown), (unknown), Angela Vitrano, Liana Cuccia, Aurelio Maggio, Silverio Perrotta, Marcello Capra, Paolo Rigano	11
13	Desensitization to hydroxycarbamide following long‐term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients 2010 ·British Journal of Haematology ·Paolo Rigano, (unknown), Roberta Calzolari, (unknown), Santina Acuto, Disma Renda, (unknown), Aurelio Maggio, Rosalba Di Marzo	37
14	Nucleated red blood cells and soluble transferrin receptor in thalassemia syndromes: relationship with global and ineffective erythropoiesis 2009 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Paolo Danise, Giovanni Amendola, (unknown), Enrìco Cillari, Maria Gioia, A. Di Palma, (unknown), Paolo Rigano, Aurelio Maggio	13
15	Electrocardiographic Abnormalities in Thalassemia Patients with Heart Failure 2009 ·Cardiovascular & Haematological Disorders - Drug Targets ·Luigi Mancuso, Andrea Mancuso, (unknown), Paolo Rigano	18
16	A critical review of non invasive procedures for the evaluation of body iron burden in thalassemia major patients. 2008 ·PubMed ·Aurelio Maggio, Marcello Capra, Alessia Pepe, Luigi Mancuso, Eliana Cracolici, Salvatore Vitabile, Paolo Rigano, Filippo Cassarà, Massimo Midiri	17
17	Potential Myocardial Iron Content Evaluation by Magnetic Resonance Imaging in Thalassemia Major Patients Treated with Deferoxamine or Deferiprone During a Randomized Multicenter Prospective Clinical Study 2003 ·Hemoglobin ·Massimo Galia, Massimo Midiri, (unknown), Alberto Morabito, Michele Rizzo, A Mangiagli, Roberto Malizia, Zelia Borsellino, Marcello Capra, Domenico Giuseppe D’Ascola, Carmelo Magnano, Calogera Gerardi, Paolo Rigano, Aurelio Maggio, (unknown)	24
18	CLINICAL AND HEMATOLOGICAL RESPONSES TO HYDROXYUREA IN SICILIAN PATIENTS WITH Hb S/β-THALASSEMIA 2001 ·Hemoglobin ·Paolo Rigano, Griffin P. Rodgers, Disma Renda, Maria Concetta Renda, Alessandra Aquino, Aurelio Maggio	19
19	Clinical and Hematological Response to Hydroxyurea in a Patient with Hb Leporbp-Thalassemia 1997 ·Hemoglobin ·Paolo Rigano, L. Manfrè, (unknown), Disma Renda, Maria Concetta Renda, (unknown), Roberta Calzolari, Aurelio Maggio	24
20	Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer 1995 ·Human Genetics ·Antonino Giambona, (unknown), (unknown), (unknown), Rosalba Di Marzo, Maria Concetta Renda, Francesca Trapani, (unknown), (unknown), Paolo Rigano, Farid Chehab, Haig H. Kazazian, Aurelio Maggio	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact